These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Kaimul AM; Nakamura H; Masutani H; Yodoi J Free Radic Biol Med; 2007 Sep; 43(6):861-8. PubMed ID: 17697931 [TBL] [Abstract][Full Text] [Related]
5. Thioredoxin binding protein-2/thioredoxin-interacting protein is a critical regulator of insulin secretion and peroxisome proliferator-activated receptor function. Oka S; Yoshihara E; Bizen-Abe A; Liu W; Watanabe M; Yodoi J; Masutani H Endocrinology; 2009 Mar; 150(3):1225-34. PubMed ID: 18974273 [TBL] [Abstract][Full Text] [Related]
6. The roles of thioredoxin and thioredoxin-binding protein-2 in endometriosis. Seo SK; Yang HI; Lee KE; Kim HY; Cho S; Choi YS; Lee BS Hum Reprod; 2010 May; 25(5):1251-8. PubMed ID: 20172870 [TBL] [Abstract][Full Text] [Related]
7. The involvement of thioredoxin and thioredoxin binding protein-2 on cellular proliferation and aging process. Yoshida T; Nakamura H; Masutani H; Yodoi J Ann N Y Acad Sci; 2005 Dec; 1055():1-12. PubMed ID: 16387713 [TBL] [Abstract][Full Text] [Related]
14. Thioredoxin-binding protein-2-like inducible membrane protein is a novel vitamin D3 and peroxisome proliferator-activated receptor (PPAR)gamma ligand target protein that regulates PPARgamma signaling. Oka S; Masutani H; Liu W; Horita H; Wang D; Kizaka-Kondoh S; Yodoi J Endocrinology; 2006 Feb; 147(2):733-43. PubMed ID: 16269462 [TBL] [Abstract][Full Text] [Related]
15. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. Nishiyama A; Matsui M; Iwata S; Hirota K; Masutani H; Nakamura H; Takagi Y; Sono H; Gon Y; Yodoi J J Biol Chem; 1999 Jul; 274(31):21645-50. PubMed ID: 10419473 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of thioredoxin binding protein-2/Txnip in human placenta: Possible involvement of hypoxia in its suppression during early pregnancy. Mogami H; Yura S; Kondoh E; Masutani H; Yodoi J; Konishi I J Obstet Gynaecol Res; 2017 Jan; 43(1):50-56. PubMed ID: 27762463 [TBL] [Abstract][Full Text] [Related]
17. PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats. Edgley AJ; Thalén PG; Dahllöf B; Lanne B; Ljung B; Oakes ND Eur J Pharmacol; 2006 May; 538(1-3):195-206. PubMed ID: 16674938 [TBL] [Abstract][Full Text] [Related]
18. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome. Deschamps D; Fisch C; Fromenty B; Berson A; Degott C; Pessayre D J Pharmacol Exp Ther; 1991 Nov; 259(2):894-904. PubMed ID: 1941634 [TBL] [Abstract][Full Text] [Related]
19. Dendritic cells derived from TBP-2-deficient mice are defective in inducing T cell responses. Son A; Nakamura H; Okuyama H; Oka S; Yoshihara E; Liu W; Matsuo Y; Kondo N; Masutani H; Ishii Y; Iyoda T; Inaba K; Yodoi J Eur J Immunol; 2008 May; 38(5):1358-67. PubMed ID: 18425727 [TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid treatment of hepatic steatosis: a (13)C NMR metabolic study. Nunes PM; Jones JG; Rolo AP; Palmeira CM; Carvalho RA NMR Biomed; 2011 Nov; 24(9):1145-58. PubMed ID: 21538633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]